Philip Morris International Inc. PM is accelerating its shift from traditional tobacco to reduced-risk products, with strong momentum in its flagship offerings — IQOS and ZYN. In the first quarter of ...
Philip Morris International’s PM smoke-free business is gaining scale, and the performance of its flagship products, IQOS and ZYN, is central to this trajectory. In the second quarter of 2025, the ...
A pioneer in modified risk tobacco products, Philip Morris International is the only company to have received a modified risk marketing claim for an electronic nicotine device. FDA concludes “Evidence ...
Philip Morris International is urging federal regulators to let it continue marketing its IQOS heated tobacco products in the U.S. as posing fewer health risks than traditional cigarettes. The tobacco ...
Philip Morris International shares fell after the company's second-quarter report, despite strong earnings and increased EPS guidance. The company is expecting to see cigarette sales volumes decline ...
Hosted on MSN
Philip Morris International Inc. (PM) Expands U.S. Operations With New IQOS ILUMA Production Line
Coatue Management holds $236.48 million worth of shares in Philip Morris International Inc. (NYSE:PM), representing 0.66% of its total 13F portfolio, helping the stock secure a place on our list of ...
The consensus analyst price target for Philip Morris International has recently decreased from $188.00 to $185.44. This reflects some revised expectations after the company’s latest quarterly results.
Experts from Philip Morris International Inc. (NYSE: PM) presented evidence to the Tobacco Products Scientific Advisory Committee (TPSAC). The committee, comprised of independent scientific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback